Asia Pacific Alopecia Treatment Options Are Getting Better With Pharmaceutical Companies Introducing Novel Therapies
Alopecia is a medical condition that causes hair to fall out from small patches, which are nearly unnoticeable, to grow back in larger patches. These patches can connect but then become more noticeable after a time. Sudden baldness can also happen on the head, in the temples, eyebrows, or other areas of the head, and even other parts of the body, such as the neck. Another medical condition that causes the hair to fall out and grow back in smaller amounts is called Alopecia Areata. People with this may not even know they have it, due to the fact that the patches grow back thinner over time, like the Alopecia Areata, instead of growing all the way out. It is also sometimes difficult to tell which pattern of baldness one is suffering from with Alopecia Areata.
One of the most widely adopted Asia Pacific alopecia treatment options includes a topical immunotherapy approach
with one that uses minoxidil. The combination approach allows the two drugs to
work together more effectively and will increase the chances that the treatment
will be successful. Topical immunotherapy is often used as a component of a
comprehensive hair loss treatment package. Often, it is combined with
finasteride, a powerful oral medication that can only be prescribed by a
physician. If topical immunotherapy is used in addition to finasteride, it can
completely eliminate hair growth from the treated follicles.
Alopecia Totalis and Alopecia Areata,
two separate forms of Alopecia, can have similar symptoms and therefore it is
vital that patients are properly diagnosed in order to determine the correct
medical approach. Alopecia totalis is characterized by the hair loss on the
chest, face, back, arms, legs, abdomen, cheeks, eyebrows, and the palms of the
hands. For women, alopecia areata is usually characterized by generalized hair
loss throughout the body, with the scalp being the most common area affected.
Since there are so many potential causes of this disease, Asia Pacific alopecia
treatment options will vary from person to person. Recently, Concert
Pharmaceuticals, Inc., a U.S.-based pharmaceutical company, received the U.S.
Food and Drug Administration (FDA) approval for Breakthrough Therapy
Designation for CTP-543 indicated for the treatment of alopecia areata.
Comments
Post a Comment